000 | 01006 a2200289 4500 | ||
---|---|---|---|
005 | 20250517035722.0 | ||
264 | 0 | _c20160331 | |
008 | 201603s 0 0 eng d | ||
022 | _a2324-8645 | ||
024 | 7 |
_a10.1089/humc.2015.2530 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aThalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia (THALAMOSS). _h[electronic resource] |
260 |
_bHuman gene therapy. Clinical development _cJun 2015 |
||
300 |
_a100-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aGenomics |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 |
_abeta-Globins _xgenetics |
650 | 0 | 4 |
_abeta-Thalassemia _xgenetics |
773 | 0 |
_tHuman gene therapy. Clinical development _gvol. 26 _gno. 2 _gp. 100-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/humc.2015.2530 _zAvailable from publisher's website |
999 |
_c24993825 _d24993825 |